{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:28Z","timestamp":1791920908180,"version":"4.3.4"},"reference-count":99,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"LOEWE Priority Program TRABITA, Hesse, Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Five-membered heteroaromatic rings, in particular, have gained prominence in medicinal chemistry as they offer enhanced metabolic stability, solubility and bioavailability, crucial factors in developing effective drugs. The unique physicochemical properties and biological effects of five-membered heterocycles have positioned them as key structural motifs in numerous clinically effective drugs. Hence, the exploration of five-ring heterocycles remains an important research area in medicinal chemistry, with the aim of discovering new therapeutic agents for various diseases. This review addresses the incorporation of heteroatoms such as nitrogen, oxygen and sulfur into the aromatic ring of these heterocyclic compounds, enhancing their polarity and facilitating both aromatic stacking interactions and the formation of hydrogen bonds. Histone deacetylases are present in numerous multiprotein complexes within the epigenetic machinery and play a central role in various cellular processes. They have emerged as important targets for cancer, neurodegenerative diseases and other therapeutic indications. In histone deacetylase inhibitors (HDACi\u2019s), five-ring heterocycles perform various functions as a zinc-binding group, a linker or head group, contributing to binding activity and selective recognition. This review focuses on providing an up-to-date overview of the different five-membered heterocycles utilized in HDACi motifs, highlighting their biological properties. It summarizes relevant publications from the past decade, offering insights into the recent advancements in this field of research.<\/jats:p>","DOI":"10.3390\/molecules28155686","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T02:10:45Z","timestamp":1690510245000},"page":"5686","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors"],"prefix":"10.3390","volume":"28","author":[{"given":"Anton","family":"Fr\u00fchauf","sequence":"first","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Haardtring 100, 64295 Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Behringer","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Haardtring 100, 64295 Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1001-3249","authenticated-orcid":false,"given":"Franz-Josef","family":"Meyer-Almes","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Haardtring 100, 64295 Darmstadt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Glomb, T., Szymankiewicz, K., and \u015awi\u0105tek, P. (2018). Anti-Cancer Activity of Derivatives of 1,3,4-Oxadiazole. Molecules, 23.","DOI":"10.3390\/molecules23123361"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1021\/jm2013248","article-title":"Oxadiazoles in Medicinal Chemistry","volume":"55","author":"Hogner","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12290","DOI":"10.1021\/acs.jmedchem.0c00530","article-title":"Amide Bond Bioisosteres: Strategies, Synthesis, and Successes","volume":"63","author":"Kumari","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nchembio.1223","article-title":"Selective Class IIa Histone Deacetylase Inhibition via a Nonchelating Zinc-Binding Group","volume":"9","author":"Lobera","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1016\/j.bmcl.2008.10.041","article-title":"Studies of the Metabolic Stability in Cells of 5-(Trifluoroacetyl)Thiophene-2-Carboxamides and Identification of More Stable Class II Histone Deacetylase (HDAC) Inhibitors","volume":"18","author":"Scarpelli","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/acschembio.7b00321","article-title":"Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs","volume":"12","author":"McClure","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1358\/dot.2007.43.9.1112980","article-title":"Vorinostat in Cutaneous T-Cell Lymphoma","volume":"43","author":"Duvic","year":"2007","journal-title":"Drugs Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1358\/dot.2009.45.11.1437052","article-title":"Romidepsin for the Treatment of Cutaneous T-Cell Lymphoma","volume":"45","year":"2009","journal-title":"Drugs Today"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/1078-0432.CCR-14-3119","article-title":"FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma","volume":"21","author":"Lee","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_11","first-page":"4","article-title":"Farydak (Panobinostat): First HDAC Inhibitor Approved for Patients with Relapsed Multiple Myeloma","volume":"9","author":"Raedler","year":"2016","journal-title":"Am. Health Drug Benefits"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5582\/irdr.2016.01024","article-title":"Development of Chidamide for Peripheral T-Cell Lymphoma, the First Orphan Drug Approved in China","volume":"5","author":"Lu","year":"2016","journal-title":"Intractable Rare Dis. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s00018-008-7554-z","article-title":"Evolution of the Arginase Fold and Functional Diversity","volume":"65","author":"Dowling","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.sbi.2011.08.004","article-title":"Structure, Mechanism, and Inhibition of Histone Deacetylases and Related Metalloenzymes","volume":"21","author":"Lombardi","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"26926","DOI":"10.1074\/jbc.M113.490706","article-title":"Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability","volume":"288","author":"Lauffer","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: Meeting Modern Challenges in Visualization and Analysis: UCSF ChimeraX Visualization System","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: Structure Visualization for Researchers, Educators, and Developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Alvarez-Builla, J., Vaquero, J.J., and Barluenga, J. (2011). Modern Heterocyclic Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA.","DOI":"10.1002\/9783527637737"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0040-4020(01)96543-3","article-title":"A New Aromaticity Index and Its Application to Five-Membered Ring Heterocycles","volume":"41","author":"Bird","year":"1985","journal-title":"Tetrahedron"},{"key":"ref_20","unstructured":"Clapp, L.B. (1984). Comprehensive Heterocyclic Chemistry, Elsevier."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1002\/ps.5874","article-title":"Trifluoromethyloxadiazoles: Inhibitors of Histone Deacetylases for Control of Asian Soybean Rust","volume":"76","author":"Winter","year":"2020","journal-title":"Pest. Manag. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e2100651","DOI":"10.1002\/cbdv.202100651","article-title":"Synthesis, Antifungal Activity, DFT Study and Molecular Dynamics Simulation of Novel 4-(1,2,4-Oxadiazol-3-Yl)-N-(4-Phenoxyphenyl)Benzamide Derivatives","volume":"18","author":"Yang","year":"2021","journal-title":"Chem. Biodivers."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116251","DOI":"10.1016\/j.bmc.2021.116251","article-title":"Discovery of Novel Class of Histone Deacetylase Inhibitors as Potential Anticancer Agents","volume":"42","author":"Saleh","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10668","DOI":"10.1038\/s41598-021-90069-x","article-title":"Novel Late-Stage Radiosynthesis of 5-[18F]-Trifluoromethyl-1,2,4-Oxadiazole (TFMO) Containing Molecules for PET Imaging","volume":"11","author":"Turkman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"114011","DOI":"10.1016\/j.ejmech.2021.114011","article-title":"Design, Synthesis, Biochemical Evaluation, Radiolabeling and in Vivo Imaging with High Affinity Class-IIa Histone Deacetylase Inhibitor for Molecular Imaging and Targeted Therapy","volume":"228","author":"Turkman","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Mielcarek, M., Landles, C., Weiss, A., Bradaia, A., Seredenina, T., Inuabasi, L., Osborne, G.F., Wadel, K., Touller, C., and Butler, R. (2013). HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration. PLoS Biol., 11.","DOI":"10.1371\/journal.pbio.1001717"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/acsmedchemlett.0c00532","article-title":"Evaluation of 5-(Trifluoromethyl)-1,2,4-Oxadiazole-Based Class IIa HDAC Inhibitors for Huntington\u2019s Disease","volume":"12","author":"Stott","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_28","unstructured":"Hebach, C., Kallen, J., Nozulak, J., Tintelnot-Blomley, M., and Widler, L. (2013). Novel Trifluoromethyl-Oxadiazole Derivatives and Their Use in the Treatment of. (WO 2013\/080120 A1), Disease. Patent."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bollmann, L.M., Skerhut, A.J., Asfaha, Y., Horstick, N., Hanenberg, H., Hamacher, A., Kurz, T., and Kassack, M.U. (2022). The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113398"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e503","DOI":"10.1038\/bcj.2016.112","article-title":"The Role of the Proteasome in AML","volume":"6","author":"Csizmar","year":"2016","journal-title":"Blood Cancer J."},{"key":"ref_31","unstructured":"Lee, J., Han, Y., Kim, Y., Min, J., Bae, M., Kim, D., Jin, S., and Kyung, J. (2017). 1,3,4-Oxadiazole Sulfamide Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the. (WO 2017\/018805 A1), Same. Patent."},{"key":"ref_32","unstructured":"Kim, Y., Lee, C.S., Oh, J.T., Song, H., Choi, J., and Lee, J. (2017). Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the Same. (WO 2017\/065473 A1)."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102800","DOI":"10.1016\/j.jbc.2022.102800","article-title":"Difluoromethyl-1,3,4-Oxadiazoles Are Slow-Binding Substrate Analog Inhibitors of Histone Deacetylase 6 with Unprecedented Isotype Selectivity","volume":"299","author":"Cellupica","year":"2023","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"K\u00f6nig, B., Watson, P.R., Re\u00dfing, N., Cragin, A.D., Sch\u00e4ker-H\u00fcbner, L., Christianson, D.W., and Hansen, F.K. (ChemRxiv, 2023). Difluoromethyl-1,3,4-oxadiazoles are selective, mechanism-based, and essentially irreversible inhibitors of histone deacetylase 6, ChemRxiv, preprint.","DOI":"10.26434\/chemrxiv-2023-6kt1w-v3"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11087","DOI":"10.1039\/D2CC03712B","article-title":"Development of the First Non-Hydroxamate Selective HDAC6 Degraders","volume":"58","author":"Keuler","year":"2022","journal-title":"Chem. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15423","DOI":"10.1038\/s41598-021-94923-w","article-title":"A Novel Orally Active HDAC6 Inhibitor T-518 Shows a Therapeutic Potential for Alzheimer\u2019s Disease and Tauopathy in Mice","volume":"11","author":"Onishi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ptacek, J., Snajdr, I., Schimer, J., Kutil, Z., Mikesova, J., Baranova, P., Havlinova, B., Tueckmantel, W., Majer, P., and Kozikowski, A. (2023). Selectivity of Hydroxamate- and Difluoromethyloxadiazole-Based Inhibitors of Histone Deacetylase 6 In Vitro and in Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054720"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice Lacking Histone Deacetylase 6 Have Hyperacetylated Tubulin but Are Viable and Develop Normally","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_39","unstructured":"Yates, C.M. (2019). Metalloenzyme Inhibitor Compounds. (US 10,357,493 B2), U.S. Patent."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1107\/S0567740875007212","article-title":"The Crystal and Molecular Structure of Thiazolidine-2,4-Dione","volume":"31","author":"Form","year":"1975","journal-title":"Acta Cryst. B. Struct. Cryst. Cryst. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1023\/A:1021217617954","article-title":"Comparative Study of the Structure of Rhodanine, Isorhodanine, Thiazolidine-2,4-Dione, and Thiorhodanine","volume":"38","author":"Enchev","year":"2002","journal-title":"Chem. Heterocycl. Compd."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/prac.19853270210","article-title":"Synthesis, Spectroscopy and Tautomeric Study of Thiazoles Substituted in Positions 2 and 4 by Hydroxy, Mercapto and Amino Groups","volume":"327","author":"Valls","year":"1985","journal-title":"J. Prakt. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1248\/cpb.32.4460","article-title":"Studies on Antidiabetic Agents. VI. Asymmetric Transformation of (.+-.)-5-(4-(1-Methylcyclohexylmethoxy)Benzyl)-2,4-Thiazolidinedione(Ciglitazone) with Optically Active 1-Phenylethylamines","volume":"32","author":"Sohda","year":"1984","journal-title":"Chem. Pharm. Bull."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/jp0366522","article-title":"Rapid Racemization in Thiazolidinediones: A Quantum Chemical Study","volume":"108","author":"Bharatam","year":"2004","journal-title":"J. Phys. Chem. A"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e202300184","DOI":"10.1002\/ejoc.202300184","article-title":"Chemistry and Applications of Functionalized 2,4-Thiazolidinediones","volume":"26","author":"Ibrahim","year":"2023","journal-title":"Eur. J. Org. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1021\/acs.jmedchem.7b00606","article-title":"Identification of a New Zinc Binding Chemotype by Fragment Screening","volume":"60","author":"Chrysanthopoulos","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"103522","DOI":"10.1016\/j.bioorg.2019.103522","article-title":"Discovery of 5-Naphthylidene-2,4-Thiazolidinedione Derivatives as Selective HDAC8 Inhibitors and Evaluation of Their Cytotoxic Effects in Leukemic Cell Lines","volume":"95","author":"Tilekar","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"103934","DOI":"10.1016\/j.bioorg.2020.103934","article-title":"Discovery of Novel N-Substituted Thiazolidinediones (TZDs) as HDAC8 Inhibitors: In-Silico Studies, Synthesis, and Biological Evaluation","volume":"100","author":"Upadhyay","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00044-011-9623-3","article-title":"Design, Synthesis, and Biological Evaluation of Novel 2,4-Thiazolidinedione Derivatives as Histone Deacetylase Inhibitors Targeting Liver Cancer Cell Line","volume":"21","author":"Mohan","year":"2012","journal-title":"Med. Chem. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/ci500762z","article-title":"Enhancing the Sensitivity of Pharmacophore-Based Virtual Screening by Incorporating Customized ZBG Features: A Case Study Using Histone Deacetylase 8","volume":"55","author":"Hou","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6748","DOI":"10.1002\/slct.202102061","article-title":"HDAC4 Inhibitors with Cyclic Linker and Non-hydroxamate Zinc Binding Group: Design, Synthesis, HDAC Screening and in Vitro Cytotoxicity Evaluation","volume":"6","author":"Tilekar","year":"2021","journal-title":"ChemistrySelect"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1021\/acs.jmedchem.1c00491","article-title":"Thiazolidinedione \u201cMagic Bullets\u201d Simultaneously Targeting PPAR\u03b3 and HDACs: Design, Synthesis, and Investigations of Their In Vitro and In Vivo Antitumor Effects","volume":"64","author":"Tilekar","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1039\/D1MD00125F","article-title":"Multi-Target Weapons: Diaryl-Pyrazoline Thiazolidinediones Simultaneously Targeting VEGFR-2 and HDAC Cancer Hallmarks","volume":"12","author":"Upadhyay","year":"2021","journal-title":"RSC Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105350","DOI":"10.1016\/j.bioorg.2021.105350","article-title":"Double-Edged Swords: Diaryl Pyrazoline Thiazolidinediones Synchronously Targeting Cancer Epigenetics and Angiogenesis","volume":"116","author":"Upadhyay","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Schweipert, M., J\u00e4nsch, N., Upadhyay, N., Tilekar, K., Wozny, E., Basheer, S., Wurster, E., M\u00fcller, M., CS, R., and Meyer-Almes, F.-J. (2021). Mechanistic Insights into Binding of Ligands with Thiazolidinedione Warhead to Human Histone Deacetylase 4. Pharmaceuticals, 14.","DOI":"10.3390\/ph14101032"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"190338","DOI":"10.1098\/rsos.190338","article-title":"N\u025b-Acetyl Lysine Derivatives with Zinc Binding Groups as Novel HDAC Inhibitors","volume":"6","author":"Wang","year":"2019","journal-title":"R. Soc. Open. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/acsmedchemlett.0c00302","article-title":"Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance","volume":"11","author":"Liu","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1248\/cpb.c14-00449","article-title":"Design, Synthesis and Biological Evaluation of Nitro Oxide Donating N-Hydroxycinnamamide Derivatives as Histone Deacetylase Inhibitors","volume":"62","author":"Tu","year":"2014","journal-title":"Chem. Pharm. Bull."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1016\/j.bmc.2015.06.015","article-title":"Synthesis and Biological Evaluation of Novel Histone Deacetylases Inhibitors with Nitric Oxide Releasing Activity","volume":"23","author":"Duan","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.pharmthera.2009.05.003","article-title":"NO Sparks off Chromatin: Tales of a Multifaceted Epigenetic Regulator","volume":"123","author":"Illi","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1021\/ml400289e","article-title":"Synthesis and Biological Evaluation of the First Example of NO-Donor Histone Deacetylase Inhibitor","volume":"4","author":"Borretto","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"19183","DOI":"10.1073\/pnas.0805514105","article-title":"HDAC2 Blockade by Nitric Oxide and Histone Deacetylase Inhibitors Reveals a Common Target in Duchenne Muscular Dystrophy Treatment","volume":"105","author":"Colussi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1016\/j.bmc.2015.04.028","article-title":"Discovery, Bioactivity and Docking Simulation of Vorinostat Analogues Containing 1,2,4-Oxadiazole Moiety as Potent Histone Deacetylase Inhibitors and Antitumor Agents","volume":"23","author":"Cai","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.04.002","article-title":"Discovery and Preliminary Evaluation of 2-Aminobenzamide and Hydroxamate Derivatives Containing 1,2,4-Oxadiazole Moiety as Potent Histone Deacetylase Inhibitors","volume":"96","author":"Cai","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1016\/j.bmc.2014.09.039","article-title":"Improved Antiproliferative Activity of 1,3,4-Thiadiazole-Containing Histone Deacetylase (HDAC) Inhibitors by Introduction of the Heteroaromatic Surface Recognition Motif","volume":"22","author":"Guan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bmcl.2018.11.027","article-title":"Development of Hydroxamate-Based Histone Deacetylase Inhibitors Containing 1,2,4-Oxadiazole Moiety Core with Antitumor Activities","volume":"29","author":"Yang","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1016\/j.bmc.2016.09.022","article-title":"Design and Synthesis of Novel HDAC8 Inhibitory 2,5-Disubstituted-1,3,4-Oxadiazoles Containing Glycine and Alanine Hybrids with Anti Cancer Activity","volume":"24","author":"Pidugu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s10495-017-1410-2","article-title":"Novel Histone Deacetylase 8-Selective Inhibitor 1,3,4-Oxadiazole-Alanine Hybrid Induces Apoptosis in Breast Cancer Cells","volume":"22","author":"Pidugu","year":"2017","journal-title":"Apoptosis"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejmech.2019.05.089","article-title":"Discovery of 1,2,4-Oxadiazole-Containing Hydroxamic Acid Derivatives as Histone Deacetylase Inhibitors Potential Application in Cancer Therapy","volume":"178","author":"Yang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1002\/ange.201002205","article-title":"An Unexpected Example of Protein-Templated Click Chemistry","volume":"122","author":"Suzuki","year":"2010","journal-title":"Angew. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cmdc.201300414","article-title":"Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8-Selective Inhibitors","volume":"9","author":"Suzuki","year":"2014","journal-title":"ChemMedChem"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Suzuki, T., Kasuya, Y., Itoh, Y., Ota, Y., Zhan, P., Asamitsu, K., Nakagawa, H., Okamoto, T., and Miyata, N. (2013). Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0068669"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1021\/acsmedchemlett.6b00239","article-title":"Development of a Potent and Selective HDAC8 Inhibitor","volume":"7","author":"Ingham","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bioorg.2017.02.002","article-title":"Novel N -Hydroxybenzamides Incorporating 2-Oxoindoline with Unexpected Potent Histone Deacetylase Inhibitory Effects and Antitumor Cytotoxicity","volume":"71","author":"Huong","year":"2017","journal-title":"Bioorg. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12039-018-1472-x","article-title":"Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-Yl)Methyl)-3-Hydroxyimino-Indolin-2-Ones: Synthesis, Biological Evaluation, and SAR Analysis","volume":"130","author":"Dung","year":"2018","journal-title":"J. Chem. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1573406414666180528111749","article-title":"Novel Hydroxamic Acids Incorporating 1-((1H-1,2,3-Triazol-4-Yl)Methyl)- 3-Substituted-2-Oxoindolines: Synthesis, Biological Evaluation and SAR Analysis","volume":"14","author":"Dung","year":"2018","journal-title":"Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1021\/acs.jmedchem.2c01985","article-title":"Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response","volume":"66","author":"Sun","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2018.01.021","article-title":"Spirohydantoins and 1,2,4-Triazole-3-Carboxamide Derivatives as Inhibitors of Histone Deacetylase: Design, Synthesis, and Biological Evaluation","volume":"146","author":"Aboeldahab","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1021\/acs.jmedchem.8b01087","article-title":"Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants","volume":"61","author":"Marek","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1021\/ja205972n","article-title":"Structural Basis of the Antiproliferative Activity of Largazole, a Depsipeptide Inhibitor of the Histone Deacetylases","volume":"133","author":"Cole","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"10642","DOI":"10.1021\/acs.jmedchem.6b01271","article-title":"Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue","volume":"59","author":"Almaliti","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Zhang, B., Shan, G., Zheng, Y., Yu, X., Ruan, Z.-W., Li, Y., and Lei, X. (2019). Synthesis and Preliminary Biological Evaluation of Two Fluoroolefin Analogs of Largazole Inspired by the Structural Similarity of the Side Chain Unit in Psammaplin A. Mar. Drugs, 17.","DOI":"10.3390\/md17060333"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejmech.2016.02.003","article-title":"Design, Synthesis and Biological Evaluation of Bisthiazole-Based Trifluoromethyl Ketone Derivatives as Potent HDAC Inhibitors with Improved Cellular Efficacy","volume":"112","author":"Gong","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1021\/acs.jmedchem.9b01792","article-title":"Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.bmc.2019.06.036","article-title":"Structure-Activity Relationship Study of Thiazolyl-Hydroxamate Derivatives as Selective Histone Deacetylase 6 Inhibitors","volume":"27","author":"Nam","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acsmedchemlett.8b00517","article-title":"Improved Selective Class I HDAC and Novel Selective HDAC3 Inhibitors: Beyond Hydroxamic Acids and Benzamides","volume":"10","author":"Bresciani","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"127367","DOI":"10.1016\/j.bmcl.2020.127367","article-title":"Development of a Selective HDAC Inhibitor Aimed at Reactivating the HIV Latent Reservoir","volume":"30","author":"Clausen","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"127197","DOI":"10.1016\/j.bmcl.2020.127197","article-title":"Discovery of Ethyl Ketone-Based HDACs 1, 2, and 3 Selective Inhibitors for HIV Latency Reactivation","volume":"30","author":"Yu","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1021\/jm4011884","article-title":"Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington\u2019s Disease","volume":"56","author":"Luckhurst","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1021\/acs.jmedchem.5b01493","article-title":"Synthesis and Biological Investigation of Oxazole Hydroxamates as Highly Selective Histone Deacetylase 6 (HDAC6) Inhibitors","volume":"59","author":"Senger","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"103988","DOI":"10.1016\/j.bioorg.2020.103988","article-title":"Exploration of Certain 1,3-Oxazole- and 1,3-Thiazole-Based Hydroxamic Acids as Histone Deacetylase Inhibitors and Antitumor Agents","volume":"101","author":"Anh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ejmech.2014.09.024","article-title":"Design, Synthesis, and Biological Evaluation of 1, 3-Disubstituted-Pyrazole Derivatives as New Class I and IIb Histone Deacetylase Inhibitors","volume":"86","author":"Yao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bmcl.2015.12.007","article-title":"Novel Thiol-Based Histone Deacetylase Inhibitors Bearing 3-Phenyl-1 H -Pyrazole-5-Carboxamide Scaffold as Surface Recognition Motif: Design, Synthesis and SAR Study","volume":"26","author":"Wen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejmech.2016.01.013","article-title":"Identification of N-(6-Mercaptohexyl)-3-(4-Pyridyl)-1H-Pyrazole-5-Carboxamide and Its Disulfide Prodrug as Potent Histone Deacetylase Inhibitors with in Vitro and in Vivo Anti-Tumor Efficacy","volume":"109","author":"Wen","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40242-018-7239-6","article-title":"Design, Synthesis and Biological Evaluation of Novel Selective Thiol-Based Histone Deacetylase(HDAC) VI Inhibitors Bearing Indeno[1,2-c]Pyrazole or Benzoindazole Scaffold","volume":"34","author":"Xu","year":"2018","journal-title":"Chem. Res. Chin. Univ."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Zagni, C., Citarella, A., Oussama, M., Rescifina, A., Maugeri, A., Navarra, M., Scala, A., Piperno, A., and Micale, N. (2019). Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Bearing a Pyrazole Scaffold and a Cinnamoyl Linker. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040945"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"104801","DOI":"10.1016\/j.bioorg.2021.104801","article-title":"Discovery of Novel Tetrahydrobenzo[b]Thiophene-3-Carbonitriles as Histone Deacetylase Inhibitors","volume":"110","author":"Gediya","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4155\/fmc-2019-0343","article-title":"Synthesis and Biological Evaluation of Thiophene-Based Hydroxamate Derivatives as HDACis with Antitumor Activities","volume":"12","author":"Yang","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"26694","DOI":"10.1074\/jbc.M803514200","article-title":"Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-Binding Domain","volume":"283","author":"Bottomley","year":"2008","journal-title":"J. Biol. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/15\/5686\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:20:40Z","timestamp":1760127640000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/28\/15\/5686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":99,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["molecules28155686"],"URL":"https:\/\/doi.org\/10.3390\/molecules28155686","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}